Next-Generation Sequencing (NGS) for Residual Disease (MRD) Monitoring in TLymphoblastic Leukemia (T-ALL)

被引：1

作者：

Roy, Ntasha ^{[1
]}

Mao, Zhengwei ^{[2
]}

Xu, Chang ^{[2
]}

Teachey, David T. ^{[3
]}

Chen, Zhiguo ^{[4
]}

Devidas, Meenakshi ^{[5
]}

Chen, Xueyan ^{[6
]}

Raetz, Elizabeth A. ^{[7
]}

Loh, Mignon L. ^{[8
]}

Hunger, Stephen P. ^{[9
]}

Wood, Brent L. ^{[1
,10
]}

机构：

[1] Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA

[2] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA

[3] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA USA

[4] Univ Florida, Biostatist, Gainesville, FL USA

[5] St Jude Childrens Res Hosp, Memphis, TN USA

[6] Fred Hutchinson Canc Ctr, Seattle, WA USA

[7] Dept Pediat, NYU Langone Hlth, New York, NY USA

[8] Seattle Childrens Hosp, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA

[9] Childrens Hosp Philadelphia, Philadelphia, PA USA

[10] Univ Washington, Dept Lab Med, Seattle, WA USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-190624

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[21] Quantitative Next-Generation Sequencing (NGS) Based Monitoring of Minimal Residual Disease (MRD) Predicts Imminent Relapse in Patients with Myeloid Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation
Rautenberg, Christina
Betz, Beate
Wieczorek, Dagmar
Hildebrandt, Barbara
Nachtkamp, Kathrin
Schuler, Esther
Gattermann, Norbert
Kobbe, Guido
Haas, Rainer
Schroeder, Thomas
BLOOD, 2017, 130
[22] DEVELOPMENT OF MINIMAL RESIDUE DISEASE (MRD) ANALYSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) BY NEXT GENERATION SEQUENCING (NGS)
Williamson, H.
Hancock, J.
Moppett, J.
Roberts, E.
HAEMATOLOGICA, 2013, 98 : 1 - 1
[23] Impact of Next-Generation Sequencing (NGS) technology on cardiovascular disease research
Xu, Fengping
Wang, Qin
Zhang, Fangfang
Zhu, Yinling
Gu, Qingquan
Wu, Liping
Yang, Lin
Yang, Xu
CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2012, 2 (02) : 138 - 146
[24] Next-Generation Sequencing (NGS)-Based Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication (FLT3-ITD+ AML) Treated with Additional Midostaurin
Herzig, Julia K.
Rucker, Frank G.
Schmalbrock, Laura K.
Blatte, Tamara J.
Weber, Daniela
Skambraks, Sabrina
Kapp-Schwoerer, Silke
Corbacioglu, Andrea
Gaidzik, Verena I.
Paschka, Peter
Panina, Ekaterina
Jahn, Nikolaus
Schrade, Anika
Theis, Frauke
Cocciardi, Sibylle
Fiedler, Walter
Salih, Helmut R.
Wulf, Gerald
Salwender, Hans
Schroeder, Thomas
Gotze, Katharina S.
Kindler, Thomas
Luebbert, Michael
Schlenk, Richard F.
Thol, Felicitas
Heuser, Michael
Ganser, Arnold
Dohner, Hartmut
Bullinger, Lars
Dohner, Konstanze
BLOOD, 2020, 136
[25] Next-Generation Sequencing (NGS)-based Measurable Residual Disease (MRD) monitoring in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication (FLT3-ITD+ AML) treated with additional midostaurin
Herzig, J. K.
Ruecker, F. G.
Schmalbrock, L. K.
Skambraks, S.
Luck, T. J.
Weber, D.
Kapp-Schwoerer, S.
Corbacioglu, A.
Gaidzik, V., I
Panina, E.
Jahn, N.
Schrade, A.
Theis, F.
Cocciardi, S.
Fiedler, W.
Salih, H. R.
Wulf, G.
Salwender, H.
Schroeder, T.
Gotze, K. S.
Kindler, T.
Luebbert, M.
Schlenk, R. F.
Thol, F.
Heuser, M.
Ganser, A.
Doehner, H.
Bullinger, L.
Doehner, K.
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 93 - 94
[26] The application of next-generation sequencing (NGS) for monitoring of Zymoseptoria tritici QoI resistance
Pieczul, Katarzyna
Wasowska, Anna
CROP PROTECTION, 2017, 92 : 143 - 147
[27] FLT3-ITD Measurable Residual Disease Monitoring in Acute Myeloid Leukemia Using Next-Generation Sequencing
Lee, Jong-Mi
Park, Silvia
Hwang, Insik
Kang, Dain
Cho, Byung Sik
Kim, Hee-Je
Ahn, Ari
Kim, Myungshin
Kim, Yonggoo
CANCERS, 2022, 14 (24)
[28] Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia
Mai, Huirong
Li, Qin
Wang, Guobing
Wang, Ying
Liu, Shilin
Tang, Xue
Chen, Fen
Zhou, Guichi
Liu, Yi
Li, Tonghui
Wang, Lulu
Wang, Chunyan
Wen, Feiqiu
Liu, Sixi
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3259 - 3266
[29] Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia
Huirong Mai
Qin Li
Guobing Wang
Ying Wang
Shilin Liu
Xue Tang
Fen Chen
Guichi Zhou
Yi Liu
Tonghui Li
Lulu Wang
Chunyan Wang
Feiqiu Wen
Sixi Liu
Journal of Cancer Research and Clinical Oncology, 2023, 149 : 3259 - 3266
[30] Flow cytometric monitoring of minimal residual disease (MRD) in adult T-ALL: A gimema multicenter study.
Krampera, M
Vitale, A
BLOOD, 1999, 94 (10) : 290A - 290A

← 1 2 3 4 5 →